Overview: Nocardia Stain TestIntroduction: The Nocardia Stain Test detects Nocardia via staining to diagnose nocardiosis, causing lung or skin infections. Following 2023 IDSA guidelines, it uses microscopy for high specificity, supporting infection screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in clinical pathology for patients with suspected nocardiosis, often in immunocompromised individuals.
Other Names: Nocardia Stain Assay, Nocardiosis Microscopy Test.
FDA Status: Laboratory-developed test (LDT), meeting clinical pathology standards for diagnostic accuracy.
Historical Milestone: Nocardia staining began in the 1900s with bacterial research. Microscopy techniques improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects Nocardia to diagnose nocardiosis, guides treatment, and evaluates patients with lung or skin infections.
Test Parameters: 1. Nocardia Presence
Pretest Condition: No fasting required. Collect slide, sputum, tissue, or bronchoalveolar lavage. Report history of lung infections, skin lesions, or immunosuppression.
Specimen: Slide (1-2 slides), Sputum (sterile container, 5-10 mL), Tissue (sterile container, 0.5-2 cma³), Bronchoalveolar Lavage (sterile container, 5-10 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: Indefinite
Sample Stability at Refrigeration: Not refrigerated
Sample Stability at Frozen: Not frozen
Medical History: Document lung infections, skin lesions, fever, or history of immunosuppression. Include current medications, especially antibiotics.
Consent: Written consent required, detailing the tests purpose, nocardiosis implications, and risks of sample collection.
Procedural Considerations: Uses microscopy with staining (e.g., modified acid-fast) to detect Nocardia in specimens. Results are available in 1-2 days, supporting rapid clinical decisions. Performed in laboratories, often for nocardiosis diagnosis.
Factors Affecting Result Accuracy: Improper slide preparation or low bacterial load can affect results. Contamination may reduce specificity.
Clinical Significance: Positive Nocardia detection confirms nocardiosis, guiding antibiotic therapy (e.g., trimethoprim-sulfamethoxazole). Negative results may require culture testing.
Specialist Consultation: Consult an infectious disease specialist or pulmonologist for result interpretation and treatment planning.
Additional Supporting Tests: Nocardia culture, chest CT, or skin biopsy to confirm nocardiosis diagnosis.
Test Limitations: Sensitivity depends on bacterial load; clinical correlation is needed. False negatives may occur in low-burden infections.
References: IDSA Nocardiosis Guidelines, 2023; Clinical Infectious Diseases, Wilson JW, 2022.
